Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2023 Sep 8;13:1282607. doi: 10.3389/fonc.2023.1282607

Corrigendum: Case report: deterioration of infantile hemangioma related to oral or nebulized administration of β2-AR agonist: three cases reports

Qiang Chen 1,2,, Yunxuan Zhang 3,, Chenyu Sun 4, Li Liu 1, Xiaoyan Luo 1, Hua Wang 1, Sili Ni 1,*
PMCID: PMC10515650  PMID: 37746293

Incorrect Affiliation

In the published article, there was an error in affiliation 1. Instead of “Department of Dermatology, Children’s Hospital of Chongqing Medical University, Chongqing, China” it should be “Department of Dermatology, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Infection and Immunity, Chongqing, China”.

In the published article, there was an error in affiliation 4. Instead of “AMITA Health Saini Joseph Hospital Chicago, University of lllinois at Chicago, Chicago, IL, United States” it should be “AMITA Health Saint Joseph Hospital Chicago, University of Illinois at Chicago, Chicago, IL, United States”.

The authors apologize for these errors and state that these do not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES